5AM Ventures
Venture Capital Est. 2002
USD 700M
Estimated FUM
- Type
- Venture Capital
- HQ
- San Francisco, CA, United States
- Founded
- 2002
- Focus
- Healthtech / Life Sciences
About
5AM Ventures is a leading venture capital firm headquartered in San Francisco and focused on investments into early-stage life science companies. We invest in the biopharmaceutical, drug delivery technology and research instrument sectors. We support companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science. 5AM works closely with our portfolio companies. Going beyond passive board roles, ours is unusually hands-on when starting companies, assuming short-term operating roles and proactively providing guidance throughout a portfolio company's life.
5AM Ventures, through our 4:59 initiative, also discovers, incubates and funds breakthrough science. We partner alongside academics and entrepreneurs - often serving as an extension of the operating team to establish proof-of-concept data that will enable a Series A Financing.
Investment Focus
Investment size
USD 500K - USD 10M
Reported investment size. Actual commitments may vary by stage, ownership and follow-on participation.
Focus Areas
Stages
Seed Series A Series B
Focus
Healthtech / Life Sciences
Specialist
Investment Geographies
Primary Markets
United States
Coverage
Country-focused Regions
North America
Coverage is a guide only.
Location
Headquarters
San Francisco, CA, United States
Office Presence
1 country
United States
2 known offices
San Francisco, CA, United States (HQ)
Boston, MA, United States
People also viewed
Foundry Group
Foundry Group is a Colorado-based venture firm that invests in early-stage and growth-stage companies headquartered in the US and Canada. Foundry Group also invests in select, newly-formed venture capital fund managers. Foundry Group formed in 2007 and originally focused on Seed and Series A investments. It raised a growth-stage fund in 2014 (Foundry Group Next), and a fund dedicated to investing in other venture funds (Foundry Group Next) in 2016.
Regardless of the size of our initial investment, the size and structure of our funds allow us to continue to fund portfolio companies through their entire financing lifecycles. In addition, our venture capital fund investments give us insight and access to a large number of venture-backed companies at varying stages while extending the reach of our overall network. In addition to providing capital, we leverage our experience in starting and growing companies, our expertise in the technology industry, and our network of relationships to help outstanding entrepreneurs and venture capital fund managers turn great ideas into great companies.
8VC
8VC is an early-stage venture capital firm based in San Francisco. 8VC's mantra is: 'the world is broken: let's fix it', and this defines our investment mantra. We look to invest in software, biotechnology, hardware, and other technology-enabled startups. We have raised separate seed stage, early-stage, co-invest and follow-on funds. 8VC was founded in 2015 by Joe Londsdale, Alex Kolicich, Jake Medwell, and Drew Oetting. We are based in San Francisco and invest throughout North America.
Venrock
Venrock is a venture capital firm headquartered in Palo Alto that focuses on disruptive early-stage technology startups. Venrock partners with entrepreneurs who have grand ambitions and want to tackle big, hard problems that most think impossible. Venrock today consists of two separate programs: a traditional venture capital program, focused on early stage investing in healthcare and technology companies; and a later-stage healthcare program, which implements a venture capital-like long-term approach to investment opportunities in small capitalization public companies and late-stage private healthcare companies.
Venrock was formed in 1969 as a venture arm of the Rockefeller family (the name Venrock being a compound of Venture and Rockefeller), who have a long history of venture-style investing dating back to the early 20th century.
Canaan Partners
Canaan Partners is an early-stage venture capital firm investing in technology and healthcare companies in the United States.
FirstMark Capital
FirstMark Capital is an early stage venture capital firm based in New York that primarily invests at the seed or Series A stage. We are proud to back the ambitious founders of the most iconic companies in the world. We provide our investee companies access to the FirstMark platform and resources, which we believe is powered by the largest network in venture capital.
FirstMark was founded in 2008 as a spinoff of Pequot Ventures, owned Pequot Capital Management.
Talu Ventures
Talu Ventures is an early stage technology investor in Australia, with a particular focus on biotechnology, medical devices and pharmaceuticals. Talu was founded in 2012 by three of the partners of CM Capital. Talu's founders have dedicated their careers to the IT and biotech industries and they understand the challenges of building companies from the ground up. In collaboration with Talu's Industry Advisors, portfolio companies can draw upon more than a century of leadership roles within a broad spectrum of successful companies. Talu has been the lead investor in more than 90 percent of its investments.